Literature DB >> 12901853

Interleukin-1 gene cluster polymorphisms in cerebral infarction.

Jae-Young Um1, Kyung-Suk Moon, Kang-Min Lee, Hyung-Min Kim.   

Abstract

Interleukin-1 (IL-1) has pleiotropic actions in the central nervous system. During the past decade, a growing corpus of evidence has indicated an important role of this cytokine in the development of brain damage following cerebral ischaemia. The expression of IL-1 in the brain is dramatically increased during the early and chronic stage of infarction. The IL-1 gene cluster on chromosome 2ql4 contains three related genes (IL-1alpha, IL-1beta, and IL-1 receptor antagonist, IL-1ra) located within a 430-kb region. Polymorphisms in the genes encoding IL-1alpha, IL-1beta, and IL-1ra have been associated with several inflammatory diseases. Therefore we hypothesized that these cytokines might be good candidates for cerebral infarction (CI). We ascertained these genotypes in 363 CI patients and 640 controls matched for age and gender. A significant increase was found for the IL-1alpha (-889) allele 2 carriers in CI patients compared with controls (chi2 = 5.633, P = 0.018, odds ratio (OR) = 1.5). Furthermore, the IL-1alpha (-889) allele 2 carriers increased the relative risk for CI in the subjects without the IL-1ra allele 2 (chi2 = 7.989, P = 0.005, OR = 1.7). There was no significant association between IL-1beta (+3,953) polymorphism and CI. These results suggest that IL-1alpha-889 and IL-1ra polymorphisms are effective in the development of CI in Koreans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901853     DOI: 10.1016/s1043-4666(03)00183-2

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations.

Authors:  Bradford B Worrall; Thomas G Brott; Robert D Brown; W Mark Brown; Stephen S Rich; Sampath Arepalli; Fabienne Wavrant-De Vrièze; Jaime Duckworth; Andrew B Singleton; John Hardy; James F Meschia
Journal:  Stroke       Date:  2007-03-01       Impact factor: 7.914

Review 2.  Interleukin-1 and acute brain injury.

Authors:  Katie N Murray; Adrian R Parry-Jones; Stuart M Allan
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

3.  Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke.

Authors:  Kathleen E Salmeron; Michael E Maniskas; Danielle N Edwards; Raymond Wong; Ivana Rajkovic; Amanda Trout; Abir A Rahman; Samantha Hamilton; Justin F Fraser; Emmanuel Pinteaux; Gregory J Bix
Journal:  J Neuroinflammation       Date:  2019-11-14       Impact factor: 8.322

4.  Association between Interleukin-1 gene single nucleotide polymorphisms and ischemic stroke classified by TOAST criteria in the Han population of northern China.

Authors:  Zheng Zhang; Li-Jun Liu; Chen Zhang; Yong-Peng Yu
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

5.  Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.

Authors:  You Yin; Yan Liu; Xiao Pan; Rui Chen; Peng Li; Hui-Juan Wu; Zheng-Qing Zhao; Yan-Peng Li; Liu-Qing Huang; Jian-Hua Zhuang; Zhong-Xin Zhao
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

6.  Association between genetic polymorphisms of interleukins and cerebral infarction risk: a meta-analysis.

Authors:  Jiantao Wang; Niannian Fan; Yili Deng; Jie Zhu; Jing Mei; Yao Chen; Heng Yang
Journal:  Biosci Rep       Date:  2016-11-03       Impact factor: 3.840

Review 7.  Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease.

Authors:  Emmanuel Pinteaux; Wesam H Abdulaal; Ilgiz A Mufazalov; Neil E Humphreys; Maj Simonsen-Jackson; Sheila Francis; Werner Müller; Ari Waisman
Journal:  J Mol Med (Berl)       Date:  2020-05-29       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.